04/30/19 – Maintaining US Global Health Leadership in an Era of Hyper-Partisanship, Government Budget Cuts and Decreased Multilateral Cooperation Lecture

Posted on

Porter DeLaney founded the Kyle House Group in 2010 after more than a decade of senior- level work in the political and international relations spheres. Over the last 15 years, Porter has served as a senior advisor and strategist to Bono and his organization ONE, and to the Bill and Melinda Gates Foundation, among other global development leaders.

Porter has been a chief architect of lobbying and advocacy campaigns that resulted in multi-billion dollar funding increases for U.S. development assistance programs, and the bipartisan passage and signing into law of major development legislation. Porter also has advised a number of Fortune 500 companies on their corporate social responsibility programs around the globe.

The Kyle House Group advises and represents a number of leading foundations, NGOs and international organizations in the global development sector, including the Bill & Melinda Gates Foundation, the UN Foundation, and leading international NGOs such as CARE, PATH, and Bread for the World. Specifically, KHG leads advocacy and outreach campaigns on topics including economic development, malaria, vaccines, clean water, agriculture development and nutrition, maternal and child health, international conservation, environmental policy, and aid effectiveness. KHG also represents and advises a number of leading multinational companies on their global corporate responsibility strategies and programs.


Tuesday, April 30 | 12:00 p.m. – 1:00 p.m.
CHS 23-105
A light lunch will be served



Questions? Contact CHIPTS at chipts@mednet.ucla.edu.

Co-Sponsored by: UCLA Global Health Institute, Center for Identification, Prevention and Treatment Services (CHIPTS), UCLA Center for Global & Immigrant Health, USC Institute on Inequalities in Global Health and DGSOM Global Health Education and Research Program.

This event is made possible by the Center for HIV Identification, Prevention and Treatment Services (CHIPTS) – NIMH grant MH058107

Related News & Events